(0.78%) 5 121.75 points
(0.12%) 38 333 points
(1.08%) 17 757 points
(0.72%) $84.17
(-4.70%) $1.561
(0.70%) $2 358.90
(0.88%) $27.60
(0.48%) $924.90
(0.02%) $0.932
(0.32%) $10.99
(-0.02%) $0.799
(-0.36%) $91.84
Live Chart Being Loaded With Signals
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally...
Stats | |
---|---|
Today's Volume | 7.20M |
Average Volume | 6.04M |
Market Cap | 33.53B |
EPS | HKD0.371 ( 2023-06-30 ) |
Last Dividend | HKD0.329 ( 2023-07-18 ) |
Next Dividend | HKD0 ( N/A ) |
P/E | 9.67 |
ATR14 | HKD0.0130 (0.14%) |
Volume Correlation
Pharmaron Beijing Co., Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Pharmaron Beijing Co., Correlation - Currency/Commodity
Pharmaron Beijing Co., Financials
Annual | 2023 |
Revenue: | HKD11.54B |
Gross Profit: | HKD4.12B (35.75 %) |
EPS: | HKD0.900 |
FY | 2023 |
Revenue: | HKD11.54B |
Gross Profit: | HKD4.12B (35.75 %) |
EPS: | HKD0.900 |
FY | 2022 |
Revenue: | HKD10.27B |
Gross Profit: | HKD3.77B (36.71 %) |
EPS: | HKD1.160 |
FY | 2021 |
Revenue: | HKD7.44B |
Gross Profit: | HKD2.68B (35.99 %) |
EPS: | HKD2.10 |
Financial Reports:
No articles found.
Pharmaron Beijing Co., Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0.329 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
HKD0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | HKD0.109 | 2020-06-01 |
Last Dividend | HKD0.329 | 2023-07-18 |
Next Dividend | HKD0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 4 | -- |
Total Paid Out | HKD1.208 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.77 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 4.60 | |
Div. Directional Score | 7.44 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
9908.HK | Ex Dividend Junior | 2023-09-18 | Annually | 0 | 0.00% | |
2161.HK | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
1161.HK | Ex Dividend Knight | 2023-06-12 | Annually | 0 | 0.00% | |
0239.HK | Ex Dividend Knight | 2023-09-29 | Semi-Annually | 0 | 0.00% | |
3848.HK | Ex Dividend Junior | 2023-07-04 | Annually | 0 | 0.00% | |
1731.HK | Ex Dividend Junior | 2023-06-23 | Sporadic | 0 | 0.00% | |
0771.HK | Ex Dividend Knight | 2023-05-31 | Sporadic | 0 | 0.00% | |
2327.HK | Ex Dividend Junior | 2023-08-03 | Sporadic | 0 | 0.00% | |
1290.HK | Ex Dividend Junior | 2023-06-14 | Sporadic | 0 | 0.00% | |
0363.HK | Ex Dividend Knight | 2023-06-01 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.139 | 1.500 | 7.22 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0605 | 1.200 | 7.98 | 9.58 | [0 - 0.3] |
returnOnEquityTTM | 0.136 | 1.500 | 9.60 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.278 | -1.000 | 7.22 | -7.22 | [0 - 1] |
currentRatioTTM | 2.98 | 0.800 | 0.122 | 0.0974 | [1 - 3] |
quickRatioTTM | 2.55 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 1.620 | 1.500 | 2.11 | 3.17 | [0.2 - 2] |
debtRatioTTM | 0.366 | -1.500 | 3.90 | -5.84 | [0 - 0.6] |
interestCoverageTTM | 10.14 | 1.000 | 7.35 | 7.35 | [3 - 30] |
operatingCashFlowPerShareTTM | 1.445 | 2.00 | 9.52 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | -0.165 | 2.00 | -0.0825 | -0.165 | [0 - 20] |
debtEquityRatioTTM | 0.772 | -1.500 | 6.91 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.357 | 1.000 | 7.38 | 7.38 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.160 | 1.000 | 8.80 | 8.80 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.265 | 1.000 | 9.64 | 9.64 | [0.2 - 2] |
assetTurnoverTTM | 0.436 | 0.800 | -0.428 | -0.343 | [0.5 - 2] |
Total Score | 10.29 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 9.53 | 1.000 | 9.14 | 0 | [1 - 100] |
returnOnEquityTTM | 0.136 | 2.50 | 9.74 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | -0.165 | 2.00 | -0.0550 | -0.165 | [0 - 30] |
dividendYielPercentageTTM | 3.83 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 1.445 | 2.00 | 9.52 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.278 | 1.500 | 7.22 | -7.22 | [0 - 1] |
pegRatioTTM | -0.601 | 1.500 | -7.34 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.223 | 1.000 | 6.93 | 0 | [0.1 - 0.5] |
Total Score | 4.60 |
Pharmaron Beijing Co.,
Pharmaron Beijing Co., Ltd., together with its subsidiaries, provides pharmaceutical research and development services to the life sciences industry in North America, Europe, Mainland China, rest of Asia, and internationally. The company operates through five segments: Laboratory Services; Chemistry, Manufacturing and Controls (CMC) Services; Clinical Development Services; Biologics and Cell and Gene Therapy Services; and Others. It offers laboratory chemistry solutions, including medicinal, synthetic, and analytical and purification chemistry, as well as computer-aided drug design services; bioscience services comprising in vitro and in vivo drug metabolism and pharmacokinetics/absorption, distribution, metabolism, and excretion solutions; and in vitro biology and in vivo pharmacology, safety assessment, and the U.S. laboratory services. The company also provides process development and manufacturing, material science/pre-formulation, formulation development and manufacturing, and analytical development services; and radiolabelled science services and early stage clinical trial services, as well as clinical research and site management services. It also provides business development; and contract research, development, and manufacturing services for pharmaceutical products. The company was incorporated in 2004 and is headquartered in Beijing, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators